บุคลากรอาจารย์อาวุโส

ผศ.ดร.ภญ. เสริมสิริ แสงรุ่งเรืองศรี ผศ.ดร.ภญ. เสริมสิริ แสงรุ่งเรืองศรี sermsiri.san@mahidol.ac.th sermsiri.san@mahidol.ac.th อาจารย์ประจำภาควิชาเภสัชกรรม

2021

1. A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy

   Turongkaravee S, Jittikoon J*, Lukkunaprasit T, Sangroongruangsri S, Chaikledkaew U, Thakkinstian A. Pharmacogenomics J 2021; 21(3): 296-307.
   
   

2. Circulating levels of interleukin-6 and interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: systematic review with meta-analysis

   Udomsinprasert W*, Jittikoon J, Sangroongruangsri S, Chaikledkaew U. Journal of clinical immunology 2021; 41(1): 11-22.
   
   

3. Cost-utility analysis of drug treatments in patients with polypoidal choroidal vasculopathy in Thailand

   Sangroongruangsri S, Chaikledkaew U*, Hanusaha P, Ratanapakorn T, Ruamviboonsuk P. ClinicoEconomics and Outcomes Research 2021; 13: 917-926.
   
   

4. Cost-utility analysis of vasoconstrictors plus albumin in the treatment of thai patients with type 1 hepatorenal syndrome

   Sangroongruangsri S, Kittrongsiri K, Charatcharoenwitthaya P, Sobhonslidsuk A, Chaikledkaew U*. ClinicoEconomics and Outcomes Research 2021; 13: 703-715.
   
   

5. Economic evaluations of artificial intelligence in ophthalmology

   Ruamviboonsuk P, Chantra S, Seresirikachorn K, Ruamviboonsuk V, Sangroongruangsri S. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2021; 10(3): 307-316.
   
   

2020

1. Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis

   Udomsinprasert W*, Jittikoon J, Sukkho S, Pojarassangkul N, Sangroongruangsri S, Chaikledkaew U. Journal of infection 2020; 81(4): 585-599.
   
   

2. Economic impact of medical genetic testing on clinical applications in Thailand

   Jittikoon J, Sangroongruangsri S, Thavorncharoensap M, Chitpim N, Chaikledkaew U*. PLoS one 2020; 15(12): e0243934.
   
   

3. Situation of Data and Pharmaceutical Information Systems in Thailand

   Suchonwanich N, Sangroongruangsri S, Kittiratchakool N, Jitruknatee A, Limpananont K, Prukpakpoom A, et al. Journal of Health Science 29(Special Issue Jan-Feb 2020)
   
   

4. Survival analysis of colorectal cancer patients in a Thai hospital-based cancer registry

   Kittrongsiri K, Wanichsuwan W, Prechawittayakul P, Sangroongruangsri S, Cairns J, Chaikledkaew U*. Expert Review of gastroenterology & hepatology 2020; 14(4): 291-300.
   
   

2019

1. A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand

   Kumluang S, Ingsrisawang L*, Sangroongruangsri S, Chaikledkaew U, Ratanapakorn T, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Thoongsuwan S, Hanutsaha P, Kulvichit K, Ratanapojnard T, Wongsawad W, Leelahavarong P, Teerawattananon Y. BMC Ophthalmology 2019; 19(1); 82.
   
   

2. Real-world safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: A prospective observational study

   Sangroongruangsri S, Chaikledkaew U*, Kumluang S, Wu O, Geue C  , Ratanapakorn T, Leelahavarong P, Ingsrisawang L, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn Clinical Drug Investigation 2019; 39(1): 115-115.
   
   

2018

1. Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis

   Sangroongruangsri S., Ratanapakorn T., Wu O., Anothaisintawee T., Chaikledkaew U. Expert Review of Clinical Pharmacology 2018; 11(9): 903-916.
   
   

2. Real-World safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: A prospective observational study

   Sangroongruangsri S, Chaikledkaew U*, Kumluang S, Wu O, Geue C, Ratanapakorn T, Leelahavarong P, Ingsrisawang L, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Singalavanija A, Hanutsaha P Clinical Drug Investigation 2018; 38(9): 853-865
   
   

2014

1. Safety of Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Systematic Review

   Sangroongruangsri S, Chaikledkaew U*. Mahidol University Journal of Pharmaceutical Sciences 2014; 41 (3): 23-30.
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ ผศ.ดร.ภญ. เสริมสิริ แสงรุ่งเรืองศรี ได้แก่ Sangroongruangsri S ;